Edwards Lifesciences (EW) Likely to Win German Injunction in Dispute W/ Medtronic (MDT)
Tweet Send to a Friend
Canaccord Genuity today maintained a Buy rating on Edwards Lifesciences (NYSE: EW) price target of $85.00. Analyst Jason R. Mills ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
